Helping our Clients Turn Hope into Reality

Andelyn Biosciences is a World Leader in Cell and Gene Therapy Contract Development and Manufacturing, supporting clients through all phases of development and commercialization. We help innovate and produce new gene therapies in order to transform, extend and save lives.
We support clients through all phases of development and commercialization.
Our Patients Define Us
The name “Andelyn” was chosen to pay tribute to two brave young patients that participated in pivotal clinical trials that make today’s gene therapies possible.
Updates from Andelyn
News
September 30, 2021
Andelyn Biosciences Inc. is adding a second laboratory in Dublin, and will move into its headquarters in Ohio State University's Innovation District before construction is complete.
Blog
September 23, 2021
The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...
Blog
September 16, 2021
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...
Media Release
August 25, 2021
TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.
Our Employees Fuel Our Success
Andelyn is made up of an Inspired, Innovative and Compassionate team that contribute towards a rich company culture. We are always looking for great people who want to do great things.